Infectious Disease and Microbiology - Alcaligenes Species

Basics

Alcaligenes is a genus of aerobic, gram-negative bacilli that are widely distributed in the environment but only rarely cause human infection. Clinically recognized species have included Alcaligenes denitrificans, A. faecalis, and A. piechaudii.

An important historical taxonomic issue involves A. xylosoxidans. This organism was previously placed within Alcaligenes, but molecular analysis, including 16S rRNA sequencing, supports its classification in the genus Achromobacter. It is therefore currently known as Achromobacter xylosoxidans.

Microbiologic Characteristics

Alcaligenes species are aerobic, gram-negative bacilli. They are environmental organisms and are generally considered opportunistic rather than highly virulent primary pathogens.

Their isolation from a clinical specimen must therefore be interpreted in the context of the patient’s symptoms, specimen source, and underlying risk factors.

Epidemiology

Alcaligenes species have a worldwide distribution, but clinically significant human infections are uncommon.

Because these organisms can survive in environmental and aqueous settings, healthcare-associated contamination has occasionally resulted in infection.

Rare outbreaks and episodes of bacteremia have been linked to contaminated medical solutions, including intravenous fluids.

Opportunistic Infection

Alcaligenes infections occur primarily as opportunistic infections.

Patients at greater risk may include those with:

• Prolonged hospitalization

• Intravascular devices

• Immunosuppression

• Serious underlying disease

• Recent invasive procedures

• Exposure to contaminated medical fluids or equipment

The presence of an indwelling vascular catheter may provide a route for bloodstream infection.

Sepsis and Bacteremia

One of the most important manifestations is bloodstream infection.

Clinical features may include:

• Fever

• Chills

• Hypotension

• Tachycardia

• Altered mental status

• Other manifestations of systemic infection

Severe cases can progress to sepsis or septic shock, particularly in medically vulnerable patients.

Contaminated Intravenous Fluids

A notable epidemiologic association is bacteremia resulting from contaminated intravenous fluids.

Because Alcaligenes species can persist in moist environments, contamination of medical solutions or equipment can occasionally produce healthcare-associated clusters of infection.

When multiple hospitalized patients develop infection with an unusual environmental gram-negative organism, a common contaminated source should be considered.

Localized Infections

In addition to bacteremia and sepsis, Alcaligenes species may occasionally produce localized infections.

The clinical presentation depends on the involved site and the patient’s underlying condition.

Potential infections may involve:

• Soft tissues

• Respiratory tract

• Urinary tract

• Intravascular devices

• Other normally sterile sites

However, these infections remain relatively uncommon.

Alcaligenes faecalis

A. faecalis is one of the better-known species associated with human disease.

Although frequently regarded as an environmental organism or occasional colonizer, it has been implicated in opportunistic infections, particularly in hospitalized or medically compromised patients.

Isolation from a normally sterile site such as blood should be taken more seriously than recovery from a potentially colonized specimen.

Achromobacter xylosoxidans - Important Taxonomic Distinction

The organism formerly called:

Alcaligenes xylosoxidans

is currently classified as:

Achromobacter xylosoxidans

This distinction is important because older textbooks and microbiology references may continue to list it under Alcaligenes.

Achromobacter xylosoxidans is particularly recognized as an opportunistic gram-negative pathogen and should not be considered a current member of the genus Alcaligenes.

Diagnosis

The primary method of diagnosis is:

Culture.

Depending on the clinical syndrome, appropriate specimens may include:

• Blood

• Catheter-associated specimens

• Respiratory secretions

• Urine

• Wound material

• Other normally sterile body fluids

Identification to the species level is helpful because antimicrobial susceptibility may differ substantially between isolates.

Interpreting a Positive Culture

Because Alcaligenes organisms may represent environmental contamination or colonization, a positive culture does not automatically establish infection.

True infection is more likely when:

• The organism is repeatedly isolated from blood

• It is recovered from a normally sterile site

• The patient has compatible clinical findings

• There is an infected catheter or another plausible source

• Multiple cultures grow the same organism

Clinical correlation is therefore essential.

Antimicrobial Susceptibility

Antimicrobial susceptibility can be unpredictable.

For this reason, definitive therapy should be based on:

Culture identification

• ●

In vitro susceptibility testing.

Empiric treatment may need to be modified once susceptibility results become available.

Treatment

Historically, carbapenems have been used for serious Alcaligenes infections.

Potential agents include:

• Imipenem

• Meropenem

Ureidopenicillins have also demonstrated activity against some isolates.

However, therapy should not be selected solely on the basis of genus identification because resistance patterns can vary.

Additional Antimicrobial Options

Depending on susceptibility testing, potentially useful agents may include:

• Ceftazidime

• Trimethoprim-sulfamethoxazole

• Fluoroquinolones

• Selected antipseudomonal β-lactams

Older literature also describes colistin as a possible option in selected resistant infections, although its role depends heavily on the specific organism and susceptibility profile.

Importance of Susceptibility Testing

A central principle in treating Alcaligenes infection is:

Do not assume susceptibility.

Treatment should be adjusted according to laboratory susceptibility results whenever possible.

This is particularly important in:

• Bacteremia

• Sepsis

• Healthcare-associated infection

• Immunocompromised patients

• Patients previously exposed to broad-spectrum antibiotics

Source Control

Antibiotics alone may not be sufficient when infection is associated with a contaminated device or fluid source.

Management may require:

• Removal of an infected vascular catheter

• Discontinuation of contaminated intravenous solutions

• Drainage of localized collections

• Removal of infected prosthetic material when appropriate

• Investigation of a possible healthcare-associated outbreak

Source control is especially important when bacteremia persists despite appropriate antimicrobial therapy.

Prevention

Prevention primarily involves rigorous healthcare infection-control practices.

Important measures include:

• Proper preparation and storage of intravenous fluids

• Sterile handling of vascular catheters

• Appropriate catheter care

• Hand hygiene

• Proper disinfection of medical equipment

• Prompt investigation of unusual clusters of gram-negative bacteremia

Identification of a contaminated common source may prevent additional infections.

High-Yield Healthcare Association

Hospitalized patient

• ●

Unusual gram-negative bacillus in blood cultures

• ●

Possible contaminated IV fluids

→ Consider Alcaligenes among the possible environmental pathogens.

High-Yield Taxonomy

Older name:

Alcaligenes xylosoxidans

Current classification:

Achromobacter xylosoxidans

This taxonomic change is particularly important when reading older microbiology sources.

High-Yield Treatment Principle

Alcaligenes infection

→ Culture and susceptibility testing

→ Select an active antimicrobial

→ Modify treatment according to susceptibility results

→ Obtain source control when a catheter, contaminated solution, or other removable focus is involved.

Exam Essentials

Genus:

→ Alcaligenes

Important species:

→ A. faecalis, A. denitrificans, and A. piechaudii

Microbiology:

→ Aerobic gram-negative bacillus

Distribution:

→ Worldwide

Human disease:

→ Rare and generally opportunistic

Important systemic manifestation:

→ Bacteremia and sepsis

Classic healthcare-associated source:

→ Contaminated intravenous fluids

Diagnosis:

→ Culture

Major treatment principle:

→ Therapy guided by antimicrobial susceptibility testing

Historically useful agents:

→ Carbapenems and ureidopenicillins

Other possible active agents:

→ Ceftazidime, TMP-SMX, and fluoroquinolones depending on susceptibility

Important former species:

→ Alcaligenes xylosoxidans

Current name:

→ Achromobacter xylosoxidans

Key clinical pearl:

→ When an unusual environmental gram-negative bacillus causes bacteremia in several hospitalized patients, investigate contaminated fluids, devices, or other common healthcare-associated sources.